Assessment of Perceived Cost to the Patient and Other Barriers to Clinical Trial Participation
Douglas Jay Weckstein, Christian A. Thomas, Ivette F. Emery et al. · Journal of Oncology Practice · 2011
PURPOSE: Less than 5% of patients with cancer participate in trials. Few studies have specifically addressed the role of cost to the patient as an influence on trial participation. Our main purpose was to determine the importance of added cost as a barrier to clinical trial participation in the community setting. Our secondary goal was to determine the most prevalent barriers to trial participation for patients. PATIENTS AND METHODS: Four community practices in New England issued surveys to consecutive cohorts of patients with cancer. Patients were assessed for eligibility for clinical trials at their practice site. Trial-eligible patients who declined participation were asked to select reasons that contributed to their decision. RESULTS: Surveys were issued to 1,755 patients. Seventy-one percent of all trial-eligible patients returned surveys. Forty-four percent of nonparticipating trial-eligible patients did not recall hearing about clinical trials from their provider. The most common reasons cited by trial-eligible patients for declining trial participation were fear of adverse effects (50%) and discomfort with random assignment (44%). Twenty-eight percent cited concerns about added cost, and 12% noted cost as the most important factor in their decision. CONCLUSION: Concerns about adverse effects and random assignment were the most common reasons cited by patients declining trial participation in four community oncology practices in New England. Cost considerations were important for a significant proportion of these patients. Many patients eligible for trial participation were not informed by their provider about the availability of research trials.
Cited by 33 works. doi:10.1200/jop.2011.000236
Authors
- Douglas Jay Weckstein
- Christian A. Thomas
- Ivette F. Emery
- Barbara F. Shea
- Alison Fleury
- Margaret E. White
- Cindy Robinson
- Stacey Frazier
- Christine Pilar
References
- Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors
- Barriers to Clinical Trial Participation by Older Women With Breast Cancer
- Impact of the Cost of Cancer Treatment: An Internet-Based Survey
- Data Analysis and Interpretation
- The Growing Financial Burden Of Health Care: National And State Trends, 2001–2006
- Clinical trial accrual among new cancer patients at a community‐based cancer center
- Barriers to Clinical Trial Participation as Perceived by Oncologists and Patients
- Organizational barriers to physician participation in cancer clinical trials.
- Understanding the attitudes of the elderly towards enrolment into cancer clinical trials
- Identifying Motivations and Barriers to Patient Participation in Clinical Trials